Please assess the completion status of the following clinical trial:

Trial Title: Maximizing Outcomes in Treating Acute Migraine

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 4.0

Eligibility Criteria:
Key Inclusion Criteria:~* Has an established diagnosis of migraine with or without aura.~* Has experienced an inadequate response to prior acute treatments.~Key Exclusion Criteria:~* Has previously received any investigational drug or device or investigational therapy within 30 days before Screening.~* Pregnant, breastfeeding, or planning to become pregnant or breastfeed during the study.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- AXS-07 (Type: EXPERIMENTAL): Taken once upon a qualifying migraine
- Meloxicam (Type: ACTIVE_COMPARATOR): Taken once upon a qualifying migraine
- Rizatriptan (Type: ACTIVE_COMPARATOR): Taken once upon a qualifying migraine
- Placebo (Type: PLACEBO_COMPARATOR): Taken once upon a qualifying migraine

Based on this trial design, predict the completion outcome and termination type (if applicable).